Cesano Alessandra
SEC insider (Form 3/4/5 filer). CIK 0001827015. Director at PUMA BIOTECHNOLOGY, INC. (PBYI) and 2 other issuers. 13 reported Form 4/5 transactions since Sep 2024; latest on Sep 14, 2026. Located in LOS ANGELES, CA.
Companies Cesano Alessandra has filed insider reports for
- PUMA BIOTECHNOLOGY, INC. (PBYI): Director
- Zymeworks Inc. (ZYME): Director
- Summit Therapeutics Inc. (SMMT): Director
Cesano Alessandra
CIK: 0001827015
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (13 total)
- Sep 14, 2026PBYI
PUMA BIOTECHNOLOGY, INC.
ExerciseDirect50K shares at avg. $2.93$147K - Sep 14, 2026PBYI
PUMA BIOTECHNOLOGY, INC.
SaleDirect62.2K shares at avg. $9.12$567K - Jun 11, 2026PBYI
PUMA BIOTECHNOLOGY, INC.
AwardDirect27K shares- - Jan 12, 2026ZYME
Zymeworks Inc.
AwardDirectStock Option (Right to Buy)
11.5K shares- - Jan 12, 2026ZYME
Zymeworks Inc.
AwardDirectRestricted Stock Unit
7.7K shares- - Jan 2, 2026SMMT
Summit Therapeutics Inc.
AwardDirectStock Option (right to buy)
3.2K shares at avg. $8.76- - Jan 2, 2026SMMT
Summit Therapeutics Inc.
AwardDirectStock Option (right to buy)
35K shares- - Jul 18, 2025PBYI
PUMA BIOTECHNOLOGY, INC.
SaleDirect27K shares at avg. $3.37$91K - Jun 13, 2025PBYI
PUMA BIOTECHNOLOGY, INC.
SaleDirect12.2K shares at avg. $3.40$41K - Jun 11, 2025PBYI
PUMA BIOTECHNOLOGY, INC.
AwardDirect27K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 14, 2026 |  PBYI PUMA BIOTECHNOLOGY, INC. | Exercise | 50,000 | $2.93 | $146,500 | Direct |
| Sep 14, 2026 | PBYI PUMA BIOTECHNOLOGY, INC. | Sale | 62,150 | $9.12 | $566,994 | Direct |
| Jun 11, 2026 | PBYI PUMA BIOTECHNOLOGY, INC. | Award | 27,000 | - | $0 | Direct |
| Jan 12, 2026 |  ZYME Zymeworks Inc. | Award Stock Option (Right to Buy) | 11,500 | - | - | Direct |
| Jan 12, 2026 | ZYME Zymeworks Inc. | Award Restricted Stock Unit | 7,700 | - | - | Direct |
| Jan 2, 2026 |  SMMT Summit Therapeutics Inc. | Award Stock Option (right to buy) | 3,219 | $8.76 | - | Direct |
| Jan 2, 2026 | SMMT Summit Therapeutics Inc. | Award Stock Option (right to buy) | 35,000 | - | - | Direct |
| Jul 18, 2025 | PBYI PUMA BIOTECHNOLOGY, INC. | Sale | 27,000 | $3.37 | $90,909 | Direct |
| Jun 13, 2025 | PBYI PUMA BIOTECHNOLOGY, INC. | Sale | 12,150 | $3.40 | $41,310 | Direct |
| Jun 11, 2025 | PBYI PUMA BIOTECHNOLOGY, INC. | Award | 27,000 | - | - | Direct |
1-10 of 13 transactions